Rayamajhi A, Acharya B, Khanal B. TP53 Mutation as Molecular Marker in the Assessment of Surgical Margin Status in Head and Neck Squamous Cell Carcinoma. Nep. J. Cancer [Internet]. 2021 Sep. 26 [cited 2024 Nov. 21];5(1):27-32. Available from: https://nepjol.info./index.php/njc/article/view/41317